BioSpace News Archive

Cutera, Inc., a leading provider of aesthetic and dermatology solutions, provided preliminary financial results for the third quarter ended September 30, 2023, as well as recent business updates.

Certara, Inc., a global leader in biosimulation, reported its financial results for the third quarter of fiscal year 2023.

Catalyst Pharmaceuticals, Inc. reported financial results for the third quarter of 2023 and provided a corporate update.

BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reports financial results for the third quarter of 2023 and filed its quarterly report on Form 10-Q for the three and nine months ended June 30, 2023 with the Securities and Exchange Commission.

Sonendo, Inc., a leading dental technology company and developer of the GentleWave® System, reported financial results for the third quarter ended September 30, 2023.

CareDx, Inc. reported financial results for the third quarter ended September 30, 2023.

Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today reported financial results for the third quarter ended September 30, 2023, and provided a business update.

Intelligent Bio Solutions Inc. (“INBS” or the “Company”) (Nasdaq: INBS), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced its financial results for its fiscal first quarter ended September 30, 2023, and provided a business update.

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Tuesday, November 14, 2023 at 8:30 a.m. Eastern Standard Time to review third-quarter 2023 financials and provide corporate updates.

Foresight Diagnostics, a leader in ultrasensitive minimal residual disease (MRD) detection testing, announced today that six studies utilizing their patented PhasED-Seq™ technology will be presented at the 65th American Society of Hematology Annual Meeting and Exposition (ASH 2023) taking place December 9-12, 2023, in San Diego, California.